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Abstract
Background: Active participation of consumers in health care decision making, policy and clinical research is
increasingly encouraged by governments, influential bodies and funders. Identifying the best way to achieve this is
difficult due to the paucity of evidence. Consumers have mixed feelings towards clinical practice guidelines (CPG)
demonstrating scepticism towards their purpose and applicability to their needs. There is no information pertaining
to consumers’ views and attitudes on the receipt of antenatal corticosteroids (ACS). The aim of this study was to
examine the barriers and enablers to receiving ACS and use of CPG amongst consumers.
Methods: Consumers were recruited from neonatal units across three district health boards (DHBs) in Auckland,
New Zealand. Participants completed a semi-structured interview or questionnaire. The questions posed and
analyses were informed by the Theoretical Domains Framework (TDF). Barriers and enablers were identified by the
presence of conflicting beliefs within a domain; the frequency of beliefs; and the likely strength of the impact of a
belief on use of CPG and receipt of ACS.
Results: Twenty four consumers participated in the study. Six domains were identified as barriers to receipt of ACS
and use of CPG. Key barriers to receipt of ACS included: difficulty retaining information conveyed, requiring further
information in a variety of formats, and time constraints faced by consumers and health professionals in the
provision and understanding of information to facilitate decision making. Barriers to use of CPG included:
uncertainty about applicability of guideline use among consumers and scepticism about health professionals
adhering too rigidly to guidelines. Enablers to receipt of ACS included: optimism toward ACS use, a strong
knowledge of why ACS were administered, improved resilience in their pregnancy and confidence in their decision
making following receipt of information about ACS. Enablers to use of CPG included: validation and standardisation
of decision making among health professionals providing care and facilitating the best care for women and their
babies.
Conclusions: Key barriers and enablers exist among consumers regarding receipt of ACS and use of CPG. These
need to be addressed or modified in any intervention strategy to facilitate implementation of the ACS CPG.
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Background
Preterm birth remains a leading cause of perinatal mor-
bidity and mortality worldwide [1]. Despite significant
efforts the overall rates of preterm birth remain un-
changed or are increasing [2]. Therefore optimising the
outcomes of preterm infants’ remains essential [1].
A number of key interventions, including the adminis-
tration of ACS have been identified to help mitigate the
short and long-term effects associated with preterm birth
[1]. A substantial body of evidence has demonstrated that
a single course of ACS administered to women within
7 days prior to preterm birth can significantly reduce the
risk of morbidity and mortality in their preterm infants.
This includes a reduction in neonatal death, respiratory
distress syndrome, necrotising enterocolitis, intraventricu-
lar haemorrhage and systemic infection within the first
48 hours of life [3]. Repeat doses(s) of ACS can be admin-
istered to women identified at on-going risk of preterm
birth 7 days or more after administration of an initial
course, to significantly reduce respiratory distress syn-
drome and a composite of serious infant outcomes [4]. A
new ACS guideline entitled: “Antenatal corticosteroids
given to women prior to birth to improve fetal, child and
adult health”[5] used gold standard methods for guideline
development [6, 7] to summarise evidence and provide
recommendations around key clinical questions related to
ACS administration [5].
Despite a large number of surveys being conducted
assessing health professionals practices related to ACS
[8–12] to the best of our knowledge there is no research
available on consumer views related to the use of ACS
for improving outcomes after preterm birth. Consumers
have been identified as one of the key stakeholders in
implementation of the new ACS CPG [5]. A ‘consumer’
has been defined as: “someone who uses, is affected by,
or who is entitled to use a health related service; a rela-
tive or carer; or someone who advocates on behalf of
broader group of people” [13]. Involving consumers in
health care research has the potential benefits of priori-
tising research questions and identifying relevant clinical
outcomes from the perspective of the consumer and
their families [14]. Consumer participation in healthcare
policy can facilitate public accountability and transpar-
ency [15, 16]. Consumers can also be actively involved in
their own clinical care to facilitate shared decision mak-
ing and empowering them to make more informed
choices [17–19].
Governments and influential bodies such as the World
Health Organisation, the Cochrane Collaboration [20], the
National Institute for Health and Care Excellence (NICE)
[21], the Consumers’ Health Forum of Australia [22] and
the Guidelines International Network [23] have increas-
ingly recognised the importance of consumer involvement
in health care [14]. The World Health Organisation’s
declaration of Alma Ata states that “People have the right
and duty to participate individually and collectively in the
planning and implementation of healthcare” [24].
In spite of organisations advocating for consumers to
be actively involved in all levels of healthcare service, a
recent Cochrane systematic review was unable to draw
any definite conclusions on how best to achieve effective
consumer involvement in the development of healthcare
policy and research, CPG and patient information due to
the paucity of evidence [16]. The authors identified the
need for further research to address this [16].
A systematic review assessing the role of patient and
public involvement in developing and implementing
CPGs identified that patients believed their greatest im-
pact would be in defining key questions to be addressed
by CPGs, helping to formulate recommendations and in
revising drafts of the guidelines to incorporate patients’
values or perspectives [25]. This mixed model systematic
review included 26 eligible studies (10 qualitative studies,
13 cross sectional studies and three randomised controlled
trials) and also identified that consumers demonstrated
mixed feelings towards guidelines, with some scepticism
as to their purpose and their applicability to their particu-
lar needs. A significant number of the participants were
unaware of the existence of guidelines [25].
There has been increasing research to improve applic-
ability and readability of CPG to facilitate dissemination,
implementation and use of guidelines amongst con-
sumers [26]. A number of organisations and professional
groups have produced consumer versions of CPG rec-
ommendations to facilitate the provision and communi-
cation of information [21, 27, 28]. The Guidelines
International Network has been particularly active in im-
proving consumer involvement by producing a meth-
odological tool kit to provide practical advice to
guideline developers using the published literature and
personal experience [29].
Unfortunately the uptake and adoption of evidence into
clinical practice can be somewhat slow and haphazard [30].
CPGs can only improve or facilitate appropriate adminis-
tration of ACS if the recommendations are adopted into
routine clinical practice. The current literature suggests
that an active tailored implementation strategy to address
identified barriers is more likely to improve professional
practice than dissemination of the guidelines alone [31].
Barriers and enablers are determinants of healthcare
practice that might prevent or facilitate improvements in
practice by modifying or mediating behaviours [32]. Bar-
riers can exist at a political, organisational, individual
and patient level [33]. A gap in the current literature
pertaining to the assessment of barriers and enablers to
implementation is that researchers focus on individual
health professional barriers and often neglect the health-
care team, the organisation and the patient [34, 35].
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The use of a theoretical framework can help to identify
and understand the behavioural barriers and enablers
that need to be altered or enhanced to facilitate effective
implementation [36]. Modelling interventions to address
pre-specified barriers or enhance enablers should facili-
tate understanding how and why interventions are suc-
cessful [36]. A significant difficulty faced by researchers
is to identify which theory to use [37]. The TDF has
been developed to integrate 128 constructs from 33
health and social psychology theories that may explain
health related behaviour change [36]. This framework
has recently been validated and includes 14 behavioural
domains and their component constructs [38] (Table 1).
The TDF has previously been used in health care to
understand consumers’ experiences in taking and adher-
ing to medication and lifestyle modifications to prevent
or optimise disease management [39–44].
The aim of this study was to identify consumers’ at-
titudes, beliefs and knowledge on the receipt of ACS
and use of CPGs and to determine their views on
barriers and enablers to their use, to inform imple-
mentation strategies for the ‘Antenatal corticosteroids
given to women prior to birth to improve fetal, child
and adult health’ clinical practice guideline (CPG
guideline 2015) [5].
Methods
Design: This was a mixed method study using in-depth,
semi-structured interviews and on-line questionnaires.
Setting
We recruited participants from four maternity hospitals
in Auckland, New Zealand. These hospitals reflect differ-
ent levels of maternal and newborn care and capture the
social and ethnic diversity of three distinctly different
DHBs in Auckland, New Zealand.
These three DHBs serve a catchment population of ap-
proximately 1,575,380 individuals (34 % of New Zealand
population) based on data projections from the 2013 cen-
sus [45]. Collectively the populations served by the
three DHBs are reflective of the overall population of
New Zealand [46].
National Women’s Health (Auckland DHB) and Middle-
more Hospital (Counties Manukau DHB) provide care to
babies who need full ventilation, or are born at less than
30 weeks’ gestation or who require intensive care support.
The neonatal service at National Women’s Health receives
babies from other New Zealand regions and cares for ba-
bies requiring neonatal surgery and other specialist ser-
vices. North Shore and Waitakere Hospitals (Waitemata
DHB) care for women with low- or medium-risk pregnan-
cies and their special care baby units can accommodate
babies from 32 weeks’ gestation onwards.
Participants
Participants were recruited postnatally from the three
DHBs within Auckland, New Zealand. Women were eli-
gible to participate if they had received a dose(s) of ACS
prior to preterm birth at or less than 34 weeks’ gestation.
Table 1 Theoretical domains framework, adapted from Cane et al. [36, 38]
Theoretical domains Definition
Knowledge An awareness of the existence of something
Skills An ability or proficiency acquired through practice
Social/Professional Role &
Identity
A coherent set of behaviours and displayed personal qualities of an individual in a social or work setting
Beliefs about capabilities Acceptance of the truth, reality or validity about an ability, talent or facility that a person can put to constructive
use
Optimism The confidence that things will happen for the best or that desired goals will be attained
Beliefs about consequences Acceptance of the truth, reality or validity about outcomes of a behaviour in a given situation
Reinforcement Increasing the probability of a response by arranging a dependent relationship, or contingency, between the
response and a given stimulus
Intentions A conscious decision to perform a behavior or a resolve to act in a certain way
Goals Mental representations of outcomes or end states that an individual wants to achieve
Memory, attention and decision
processes




Any circumstance of a person’s situation or environment that discourages or encourages the development of skills
and abilities, independence, social competence, and adaptive behaviour
Social influences Those interpersonal processes that can cause individuals to change their thoughts, feelings or behaviours
Emotion A complex reaction pattern, involving experiential, behavioural and physiological elements, by which the individual
attempts to deal with a personally significant matter or event
Behavioural Regulation Anything aimed at managing or changing objectively observed or measured actions
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Potential participants were identified by a member of the
neonatal or obstetric team at each of the recruiting hos-
pital sites and invited to take part by one of the researchers
(EM). A participant information sheet was provided and
written consent was obtained from all participants prior to
taking part in the study. Participants were randomised into
completing either a semi-structured interview or question-
naire. This study was nested within a randomised trial to
assess different methods for identifying barriers and en-
ablers to administration of antenatal corticosteroids. The
results from this comparison will be reported elsewhere.
Eight individuals were recruited at each of the three
DHBs to facilitate data saturation in the thematic ana-
lysis. Ethical approval was obtained by the University of
Auckland Human Participants Ethics Committee (011193)
and locality agreement was obtained at each of the partici-
pating sites.
Materials
The TDF [36, 38] informed the development of the
questions used in both the semi-structured interviews
and on-line questionnaires (Additional file 1). The ques-
tions were developed to provide uniformity of assess-
ment in eligible groups (semi-structured interview and
questionnaire) and were piloted by three consumers to
ensure clarity of the questions and minimise repetition.
The questions explored:
1. Attitudes, beliefs and knowledge on the receipt of
ACS
2. Knowledge and beliefs of CPGs;
3. Additional resources required to facilitate decision
making
Interview procedure
Semi-structured, face to face interviews were conducted
by a single researcher (EM) who had training in inter-
view skills. Interviews were conducted in the neonatal
unit at the respective hospital sites, at a time convenient
to the women and their partners. No explicit time re-
straints were applied for the interviews.
Questionnaire procedure
The questionnaires were developed on the web based
system, Survey Monkey®, and were emailed to the partic-
ipants preferred email address to be completed at a time
convenient to them. For participants without access to a
computer a paper version of the questionnaire was pro-
vided and collected following completion. Participants
were asked to insert their unique identifying number at
the beginning of the questionnaire to allow identification
of responders. A reminder via email or text message was
sent to non-responders 2 weeks after the initial ques-
tionnaire had been sent.
Data collection and analysis
The semi-structured interviews and online question-
naires were conducted over an eight month time period
(April to November 2014). Following each interview, the
digital recordings were transcribed verbatim by a single
researcher (EM). The transcripts were verified by an-
other researcher (TC) and entered into NVivo8 [47] for
data management and analysis. The transcripts were
read and re-read by both reviewers (EM, TC) to familiar-
ise themselves with the data. A deductive process of the-
matic analysis was used to classify responses into one or
more of the 14 theoretical domains using the TDF [36,
38]. Both reviewers coded the semi-structured interview
data and open ended questionnaire responses independ-
ently. This process was iterative and involved discussion
between the two reviewers and consultation with the
other members of the research team (CAC, KG, JB).
Lists of specific beliefs were then generated to represent
the overarching statements coded within each behav-
ioural domain [48]. The two reviewers decided whether
the beliefs would represent a barrier or enabler to re-
ceipt of ACS and use of CPG. A frequency count illus-
trated the strength of beliefs within domains.
Data saturation was assessed throughout sampling,
data collection and data analysis. No further participants
were required after initial recruitment as no new themes
were emerging from the data.
Results
A total of 24 consumers completed either a semi-
structured interview (11) or questionnaire (13) (Fig. 1).
Participants were predominantly aged between 30 and
39 years (58 %), of New Zealand European ethnicity
(46 %) and had received a single complete course of
ACS (54 %) (Table 2). All participants had given birth
prior to 34 weeks’ gestation and the commonest co-
morbidity reported was preterm prelabour rupture of
membranes (PPROM) (18 %). Of those women complet-
ing the interview 7/11 (64 %) were interviewed alone,
the remainder had their partner or another family mem-
ber in attendance. Our study population is representative
of the cohort of mothers and babies admitted to neo-
natal units across New Zealand in relation to maternal
age (ANZNN 2013: 49 % of level 3 registrants aged 30–
39 years) ethnic diversity (ANZNN 2013: 52.3 % level 2
and 52.6 % of level 3 registrants were Caucasian), and
indications or reasons for preterm birth (ANZNN 2013:
PPROM 18 % level 2 and 3 registrants) when compared
to data from the Australia and New Zealand Neonatal
Network data [49].
Barriers and enablers
The behavioural domain of environmental context and
resources was identified as a barrier to the receipt of
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ACS. Some behavioural domains were identified as bar-
riers and enablers to the receipt of ACS. The four behav-
ioural domains identified as mixed barriers and enablers
to the receipt of ACS included: knowledge, memory atten-
tion and decision processes, emotion and belief about
capabilities. Five additional behavioural domains were
identified as enablers alone, to receipt of antenatal cortico-
steroids. These were: optimism, social influences, goals,
belief about consequences and behavioural regulation.
One behavioural domain (social professional role and
identity) was identified as a barrier and enabler to the
use of CPG. A further three behavioural domains were
identified as enablers alone. These were: knowledge, op-
timism and goals.
The barriers and enablers to receipt of ACS and use of
CPG are discussed in further detail within their respect-
ive behavioural domains. Key responses are demon-
strated by direct quotes from participants. Theoretical
domains not linked to barriers or enablers were skills,
reinforcement and intentions.
Environmental context and resources
This domain reflects the situation or circumstance
that influences the individual’s ability to make deci-
sions. Participants reported time constraints as a sig-
nificant barrier to receiving and understanding the
information on ACS. This was reflective of the acute
nature of the situation in which they presented, ne-
cessitating urgency in both their and the health pro-
fessionals decision making.
“So I can’t remember a lot of thing they said because
at the time it’s like,… you know painful and then at
the same time the nurse comes and says…ah this
medicine is good” (site 3, participant 3).
Consumer consented and randomised 
N=29
Eligible Consumers approached by key 





Fig. 1 Flowchart of recruitment
Table 2 Demographics of participants included in the study
Age group (years) Number (% of total)
< 20 years 0
20–29 3 (13 %)
30–39 18 (75 %)
≥ 40 3 (13 %)
Ethnicity
European 11 (46 %)
Maori 5 (21 %)
Pacific Island 4 (17 %)
Asian 3 (13 %)
Middle Eastern/Latin American/ African 1 (4 %)
Employed
Yes 18 (75 %)
Co-morbidities in pregnancy (by consumers)
Premature rupture of membranes 11 (46 %)
Multiple pregnancy 10 (42 %)
High blood pressure/pre-eclampsia 4 (17 %)
Antepartum Haemorrhage 4 (17 %)
Diabetes 3 (13 %)
Intrauterine growth restriction 2 (8 %)
Othera 4 (17 %)
Complete course of antenatal corticosteroids
Yes 18 (75 %)
No 2 (83 %)
Unsure 4 (17 %)
aOther: 2 participants’ twin-twin transfusion and 2 participants had a
cervical cerclage
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However on occasion consumers had been identified
as high risk of preterm birth early in their pregnancy
and been seen by members of the health professional
team. Consumers expressed the preference to receive
the information as soon as possible to facilitate their de-
cision making.
“So you could have a read through but obviously,
something like when your waters break you don’t
have enough time to go through that. But yeah, for
those ladies they know their placenta is small or they
are probably going to have little babies….something is
going to happen. So in that case leaflets would be very
good” (site 3, participant 4).
“I suppose it’s hard because I was preterm, it would
be nice to get it earlier maybe through antenatal
classes, as at the time you are under pressure” (site 2,
participant 6).
This was linked to the belief that once consumers had
been identified as high risk they had limited contact with
their lead midwife and their care was primarily with the
hospital health professional staff and therefore felt very
reliant on a limited number of individuals for their
information.
“No my midwife after I got pregnant I think I saw her
only about two times. After I give birth to the baby I
think I only saw her last week. I didn’t see her much”
(Site 1, participant 7).
“Probably the ones in hospital because I didn’t have
much to do….I only had one appointment with my
midwife. Yeah, the obstetrician, even though she was
really good we didn’t get a chance to discuss much”
(Site 2, participant 1)
Knowledge
Within our study, this domain reflected participant’s
knowledge of the receipt of ACS including the name of
the ACS administered, the dose and number of courses
received and why they were administered. The majority
of participants (21/24, 88 %) were aware that ACS were
administered to improve fetal lung maturity.
“Doctors and my obstetrician explained that due to
my membranes breaking at 20 weeks’ the steroids
would help with my babies lung development (site 2,
participant 2)
Many women identified that they were aware of the
number of injections (courses) they received but were
unsure of the name of the ACS used or the dose admin-
istered and would like this information in the future if
ACS were required.
“I was given info on all processes throughout treatment
as well as during the procedure of my caesarean
however I am unsure on the exact injections and/or
medication used at present” (site 3, participant 8).
The knowledge domain also referred to consumers’
awareness of the existence of CPG and why they were
used. When asked about the use of CPG in assisting
health professionals to make decisions about their care,
a large proportion of participants were aware of the use
of guidelines (20/24, 83 %) and why and how they
should be used (17/24, 71 %).
“Making clear about the time to give and the specific
purpose,…clarifying how to use them” (site1,
participant 1).
Memory attention and decision processes
This domain reflected the ability of the consumer to re-
tain the information they received regarding ACS and
use this to make decisions about their care. This domain
appeared to represent the most significant barrier related
to the understanding of the use of ACS. The majority of
consumers (14/23, 61 %) expressed the belief that in a
future pregnancy they would like more information re-
garding ACS and their administration. The degree of in-
formation required varied as reflected in the comments:
"What could be good is exactly why the steroids are
given, the names of the steroids say and the impact
physiologically on the child and the mother and how
that, how that hmm, how that would develop as your
number of doses increased or something. So I don’t
know. I know I had steroids but I don’t know exactly
what. Whereas I normally would find out I think" (site
1, participant 2).
“Hmm, personally in this sort of situation because I
know so little myself I have to rely on the professionals.
Because I have already been through it, I would
probably investigate a bit more” (site 3, participant 7).
A number of participants (11/24, 46 %) remembered
being given the information but due to the nature of the
clinical situation they cannot necessarily recall every-
thing that was said.
“The information given at the time was all that was
necessary and explained very well, although it is again
hard to remember as it was an emergency situation and
I was scared of the outcome” (site 3, participant 8).
Consumers identified that having the information in a
written format alongside verbal communication would
facilitate understanding and retention of what was said.
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“Written material would be useful, antenatal classes:
mention preterm labour and add in information about
steroids” (site 2, participant 3) (in response to the
question: In a future pregnancy would you find it
helpful to receive more information)
“Something written would be good. Hmm just so you
can…Hmm you know you don’t take it all in when
someone is telling you something. But if you can sit
there and read something, you know” (site 2,
participant 1).
Emotion
This domain represents the reaction patterns with which
the individual responds to a personally significant matter
or event. This domain was represented strongly in the
interviews and surveys completed by the participants. A
significant barrier reported by participants to their usual
decision making processes was the fear they experienced
in being identified as at risk or being in preterm labour
and the impact this had on their decisions. This is
reflected by the comments:
“I think it was because it was late at night and I was
tired and freaked out” (site 2, participant 6).
“we were quite frantic” (site 1, participant 5).
On occasion, frustration was expressed at the appreci-
ated uncertainties in the evidence base and the impact
this had on both them and their health professionals’ de-
cision making.
"And no one knows which one is right. You are
thinking well that’s no help what so ever" (site 1,
participant 2).
Consumers expressed confidence in their decision
making when they had been given adequate information
on when and how ACS should be administered.
“Because you can read that and you kind of know
what you are in for” (site 2, participant number 2).
“So it might be a little bit familiar to you, you can
think ahh, I have actually heard that before. So you
are more confident in the decision that you are
making” (site 2, participant 6)
Belief about capabilities
Within our study, this domain refers to an individuals’
ability to use their knowledge on ACS to make decisions
about their care. A notable barrier within this domain
was the belief by one individual that it was the doctors
that made the decision on ACS administration rather
than themselves.
“Well I did not take that decision it was made by the
doctors. They explained it to me but yeah I did not
have the decision” (site 2, participant 8).
However the majority of participants (23/24, 96 %) felt
engaged in the decision making process and believed
that they were able to use their own judgement to make
the decision on whether to receive ACS with input from
the clinical team.
“A the end of the day I make my decisions” (site 3,
participant 5).
Another enabler identified within this behavioural do-
main was that consumers felt empowered when they re-
ceived adequate information on ACS and reported that
having the information on ACS allowed them to be
confident and informed in the decision they were making.
“So if you just gather as much information as you can
then you are as informed as you can be” (site 2,
participant 6).
Interestingly some participants reported some diffi-
culty in their decision making. This occurred when par-
ticipants were informed of the uncertainties in the
evidence base as perceived by their health professionals
relating to the use of repeat dose(s)/course(s) of ACS.
“It was a good conversation but it was like, there is no
right or wrong on this. Which I assume there isn’t
because everyone seems to have their own opinion”
(site 1, participant 2).
Optimism
This domain reflected individuals’ confidence that ad-
ministration of ACS happens for the best and that ad-
herence to CPG will result in the desired goals being
obtained. This domain represented a key enabler to ACS
use. All participants considering a future pregnancy re-
ported that they would be happy receiving further
course(s) or dose(s) of ACS if they were at risk of a pre-
term birth in a subsequent pregnancy.
“I was pretty determined that it was the right
thing……..and they actually helped with some of my
pregnancy symptoms, my swelling went down and I felt
a lot better about myself” (site 1, participant 5).
Yes, I would…I’d like to get them earlier if I could”
(site 3, participant 6).
Social Influences
This domain referred to the interpersonal processes that
assisted consumers in making their decisions regarding
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receipt of ACS. Consumers reported that they relied very
much on the medical staff when they were making deci-
sions about their care and the care of their baby.
“Usually the doctors or the nurses, they advise me
what it is for. They are the most important ones
because they know it better and I feel they wouldn’t
give me the wrong advice” (site 3, participant
5).Consumers identified that they also received
support from family members and their partners
when making important decisions about their care.
“Yeah my other sister, she has got two babies as well.
She is the one that explains everything about having a
baby. So she knows lots of things, so I ask her
that,…..so what the next step is and she helps me”
(site 3, participant 3).
Goals
This domain reflects the mental representations of out-
comes or end states that an individual wishes to achieve.
Consumers were asked what they thought the purpose of
the new ACS guidelines should be. Among individuals
who were aware of CPG (20/24, 83 %), a consistent state-
ment was that they felt adherence to CPG provided health
professionals with a structure and ensured validation and
standardisation of their decision making (7/17, 41 %).
“Well I mean they need to have a structure…I guess
validate them and not just make a big decision,
without sort of checking them and validating them
through a regulated higher party" (site 1, participant
number 5).
“To have a general rule across the board of the
administration of steroids” (site 2, participant 5).
Beliefs about consequences
This domain represents acceptance of truth, reality or
validity about outcomes of a behaviour in a given situ-
ation. Within our study this relates to consumers views
on the efficacy of ACS and their use in preterm birth. A
significant proportion of the consumers (22/24, 92 %)
felt that ACS were hugely beneficial in the treatment of
preterm babies.
“I felt that they really helped my son” (site 3,
participant 5).
Overall the majority of consumers (23/24, 96 %) were un-
able to identify any particular reasons they would not be
happy receiving antenatal corticosteroids in a future preg-
nancy if indicated. However, two consumers were mindful
of the need to ensure that ACS are only given when appro-
priate and emphasised that consideration needs to be taken
in preventing unnecessary use and informing women of
potential side effects or adverse reactions associated with
antenatal corticosteroid administration.
“Maybe a reference to a website so that I could read
more about the side effects etc” (site 2, participant 2).
“Hmm not if I knew that they were preterm,… or
unless some research came out that very strongly
suggested otherwise” (site 1, participant 2)
Behavioural regulation
This domain refers to anything aimed at managing or
changing objectively observed or measured actions. Spe-
cifically consumers were asked if in a future pregnancy
they would like to receive any further information. As
mentioned within the domain memory, attention and
decision processes a significant proportion requested
more information (14/23, 61 %). Additionally a number
of participants also expressed that having time and infor-
mation about ACS administration helped to facilitate
their decision making.
“I think it is important to know what they are doing
and why. Ah…first my doctor in XX said it was an
option to do it if the baby arrived before 34 weeks.
Later here when the lady gave the steroids she
explained before and I think we read some
information the doctor gave me” (site 1, participant 4)“
“I thought, that we could of talked about it right at the
start…worst case. But the thing is we didn’t know what
was going to happen…..But I guess in hindsight maybe
just mention it, There’s you know….there is good
precautions like steroids that could help the twins”
(site 1, participant 5).
Social professional role and identity
This domain reflects the individuals’ behaviours and
perceived identity within their current situation or
setting. However, when consumers were asked ques-
tions regarding their own social professional roles and
identity many reflected what their expectations of
their health professionals was, as opposed to their
role in the use of CPG or in their decision making
around ACS. When asked what they thought the pur-
pose of the ACS guidelines should be, a frequent
statement by consumers (6/17, 35 %) was the belief
that guidelines help doctors in their decision making
and ensures the provision of the best possible care to
every woman and her baby (3/17, 18 %).
“To provide best practice information/guidance for
care providers” (site 3, participant 4)
“To provide the best care, informed treatment for both
the practitioner and the patient” (site 3, participant 7).
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Consumers felt that a key enabler of CPGs is that they
reduce reliance on individual health professionals’ deci-
sion making and facilitate consistency of care among
health care providers (7/17, 41 %).
“To provide a consistency of care” (site 3, participant
1) (In response to the question: What do you think the
purpose of the antenatal corticosteroid clinical practice
guideline should be)
Within this domain one barrier identified was the be-
lief by some consumers that health professionals should
use guidelines to assist in their decision making but also
felt there should be flexibility to allow care to be indivi-
dualised when necessary (3/17, 18 %).
“I think they should use guidelines as well as own
experience/knowledge as I understand that all
pregnancies are different” (site 2, participant 7).
Discussion
In this study the validated TDF helped to assess con-
sumer’s views and attitudes on the administration of
ACS and use of a CPG. An extensive literature search,
has demonstrated that although the TDF has been used
among consumers to assess behaviours related to acces-
sing health services and acceptability of interventions for
the prevention or treatment of diseases [39–44], this is
the first study to our knowledge to use the TDF to
understand consumers’ beliefs towards the receipt of
ACS.
Despite a relatively modest sample size, data saturation
was reached with the number of participants included in
the study. Our study population was representative of
the cohort of mothers and babies admitted to neonatal
units across New Zealand in relation to social diversity
and indications or reasons for preterm birth, when com-
pared with data from the Australia and New Zealand
Neonatal Network data (ANZNN 2013), therefore ensur-
ing wide applicability of results. A limitation of our
study is that due to the modest sample size we weren’t
able to assess differences between different ethnic
groups or study locations.
Our study demonstrated that women’s knowledge on
why ACS had been administered and the number of
courses they had received was very comprehensive.
Women demonstrated significant optimism in receipt of
ACS and reported belief in the consequences that ad-
ministration of ACS improved the outcome of their pre-
term babies.
The main barrier identified by consumers in the re-
ceipt of ACS was within the behavioural domain of en-
vironmental context and resources. Time constraints
and the timely provision of information were perceived
by women as key factors hindering the receipt and re-
tention of information on ACS. Consumers’ reported
that memory, attention and decision making would be
improved by provision of more information on ACS.
Furthermore within the domain of behavioural regula-
tion consumers expressed that once they have been
identified as at high risk of preterm birth, information
should be provided as soon as possible and ideally in
both written and verbal formats to facilitate their deci-
sion making. This was particularly evident in women
who had been identified at risk of preterm birth at very
early gestations and were often admitted to hospital for
prolonged periods. Consumers believed that availability
and provision of this information would help both them
and the health professionals who were providing care in
an often acute or time pressured situation.
These beliefs were closely linked to the behavioural
domain of emotion. Many women expressed that the
predominant emotions associated with being identified
at risk or being in preterm labour were fear and anxiety.
This strongly impacted on their ability to retain any in-
formation that was provided. An earlier qualitative study
to identify how women cope with the stress of preterm
labour found that stress was attributed to feelings of ner-
vousness related to their situation, the lack of control to
important aspects in one’s life, and the happening of un-
expected events [50]. In attempting to deal with poten-
tially negative situations many individuals struggle to
encode and evaluate the information provided into
memory and focus instead on bracing themselves for an
undesired outcome [51].
A number of women in our study reported that the
provision of information or recollection of a discussion
on ACS prior to being in preterm labour helped gener-
ate confidence in their decision making. These findings
are supported by studies which investigated the impact
of varying amounts of information prior to diagnostic
tests. For example in a qualitative study assessing
women’s perspectives of the fetal fibronectin test to as-
sess risk of preterm labour women’s anxiety related to
preterm labour was diminished when women received a
clear explanation of the potential outcomes prior to the
test [52].
Within the domain of social influences, a large propor-
tion of women reported relying on members of the
health care team when making decisions about their care
and the care of their babies. In particular doctors, nurses
and midwives were who consumers reported relying on
most. This is consistent with other studies that have
identified health care providers as the most important
source of information in pregnancy [52–55]. Many con-
sumers felt empowered by these discussions and be-
lieved in their own capabilities in using this information
to make decisions about their care. This is particularly
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important as studies have demonstrated that women of
childbearing age are very engaged group who often re-
port wanting more information and who like to be ac-
tively involved in any decision making [56–59].
Unfortunately, in a limited number of cases, the con-
verse was true and consumers reported feeling disen-
gaged from the decision making and that the decision
on receiving ACS was made by their health professionals
and not themselves, suggesting a need for improvement.
This is critically important in the context of shared deci-
sion making as there are numerous afforded benefits to
the patient and the health professional when patients
feel that they have made an informed choice [60, 61].
These include: improved patient-physician relationships
[62]; increased sense of responsibility for themselves and
their baby [63]; improved satisfaction [63–66] and lower
levels of fear [67].
A number of women reported relying on family and
friends for peer support in their decision making. This
suggests that to facilitate appropriate ACS administra-
tion efforts should be made to include not only women
but also their partners and other family members when
providing information and discussing administration of
ACS. In addition studies in the literature have identified
that social support can help patients feel an increased
sense of perceived control over a health condition and
help manage the uncertainty [68, 69], which would seem
particularly important to women at risk of preterm
birth.
Through the process of this study, we have elicited con-
sumer’s beliefs and knowledge of a CPG. A large propor-
tion of women who participated in the study had
knowledge of the existence of CPGs. However participants
often reflected the purpose of a CPG to their use among
health care organisations and health professional rather
than to themselves. Overall, the majority of women viewed
CPGs in a positive light. However a number of consumers
believed that there needed to be flexibility to allow their
health professionals to individualise care when they felt
appropriate. This suggests the need to emphasise to con-
sumers where the recommendations and evidence from
CPGs are generated from in the CPG itself or in accom-
panying patient information materials.
Despite a significant number of participants expressing
the need for further information, or clarification related
to ACS, no participants commented that they would ac-
cess a CPG to attempt to address their concerns. These
findings are supported by the systematic review con-
ducted to assess patient and public attitudes to and
awareness of CPGs [25]. This systematic review reported
that several studies had identified that individuals
expressed concern that guidelines did not personally
help them and were not necessarily applicable to their
particular needs. This identifies the ongoing need for
guideline groups to engage with consumers and consumer
groups in the development of clinical practice guidelines
to ensure applicability and to foster confidence in clinical
practice guidelines and their recommendations.
Through the process of this study we have identified
significant behavioural determinants to be modified or
addressed in any guideline implementation strategy. Key
functions to an implementation strategy could include
training to assist health professionals in providing com-
prehensive information on ACS and their administration
to consumers. Also, providing feedback to health profes-
sionals that women identified at risk of preterm birth re-
quested the provision of information as soon as possible,
in both written and verbal formats, to facilitate sufficient
understanding and retention of the information pro-
vided. The use of decision aids [70–72] and interactive
health communications [73] have demonstrated positive
effects on users particularly in increasing knowledge and
reducing decisional uncertainty. However consideration
is needed on how and when this information can best be
delivered [70, 74]. In the context of our study, women
reported being able to recall information on ACS or
even hearing of “ACS” prior to being offered them in the
acute situation enabled them to feel more confident in
their decision making suggest the need to inform health
professionals that this information should be provided as
soon as possible..
Involving consumers in the development of patient in-
formation leaflets would ensure that there is sufficient
detail provided to address their uncertainties and con-
cerns and ensure the information is readable and under-
standable. The results from this study suggest that the
implementation strategy needs to include the patient
and members of her family to enable social support in
stressful situations. Any information should be provided
to all individuals involved in the consumers’ decision
making processes.
Implementation interventions could focus on educating
consumers on the existence of the relevant CPG and their
applicability to them and to facilitate use by them and
their families. This could be facilitated by the use of post-
ers in clinical areas frequented by consumers explaining
how guidelines are synthesised and how they can be
accessed and used to facilitate shared decision making.
Further research needs to be undertaken to identify
which barriers and enablers to target and to map these
barriers and enablers to appropriate intervention func-
tions [75] and behavioural change techniques [76].
Conclusions
Our study has identified the barriers and enablers to receipt
of ACS and use of CPGs, as perceived by New Zealand
consumers. The information gathered by our study pro-
vides new information on consumer’s views regarding the
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receipt of ACS including the need to be more actively in-
volved in decision making and for the information provided
to be more detailed and delivered in a timely manner. This
study adds to the current literature relating to consumers
views on the use of CPGs and reiterates the need for con-
sumers to be more actively involved in CPG development
and to encourage their use among consumers. The infor-
mation generated from our study will be used to develop
methodologically rigorous intervention strategies and ul-
timately facilitate implementation of the new ACS clinical
practice guidelines.
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